Question 1

What is the history and background of Invimed?

Accepted Answer

Invimed opened its first clinic in Warsaw in 2001, establishing a specialised centre for infertility diagnosis and treatment. Rapid growth followed: new locations launched in Poznań and Wrocław in 2006, Gdynia in 2010, Katowice in 2013, and a sixth clinic on Warsaw’s Praga district in August 2022. Over two decades the network has facilitated more than 13 000 births, achieving a cumulative IVF success rate of 62% and a 68% pregnancy rate for egg‑donation cycles. The clinic holds certifications from the European Society of Human Reproduction and Embryology (ESHRE) and the Polish Society of Reproductive Medicine, and its laboratories are accredited to international quality standards. Continuous investment in advanced technologies and staff training underpins Invimed’s reputation as a leading fertility provider in Poland.

Question 2

What are the IVF success rates at Invimed?

Accepted Answer

Invimed reports an overall pregnancy rate of 62% across all IVF cycles, with the first cycle achieving an even higher success of 64%. Data collected from 2017‑2021 for IVF, ICSI and IMSI procedures show that more than six out of ten couples become pregnant after their initial attempt. Recent figures for 2022‑2024 indicate a 65% clinical pregnancy rate per embryo transfer for patients who produced six or more mature oocytes. Age‑specific outcomes are also disclosed: 69% of women under 35 and 62% of those aged 35‑39 achieve pregnancy in their first cycle. The clinic’s egg‑donation program delivers a 68% success rate, meaning seven out of ten recipients conceive after using donor oocytes. All results are audited internally and align with European Society of Human Reproduction and Embryology (ESHRE) standards, providing transparent benchmarks for prospective patients.

Question 3

Who are the fertility doctors and specialists at Invimed?

Accepted Answer

Invimed’s medical team includes a broad range of reproductive endocrinologists and gynaecologists with extensive IVF experience. Key physicians are Dr. Kinga Ziółkowska (reproductive endocrinology), Dr. Jarosław Kaczyński (gynaecology‑obstetrics), Dr. Wojciech Rawski (gynaecology), Dr. Magdalena Czekańska‑Rawska (andrology and gynaecology), and Dr. Marcin Kuczerowski (gynaecology‑obstetrics). The Warsaw Mokotów clinic also lists Dr. Tomasz Dworniak as medical director. Across the network, five embryologists hold ESHRE certification, and the laboratory staff includes 26 specialists in embryology, biology and biotechnology. This multidisciplinary team collaborates with fertility nurses, care coordinators and psychologists to guide patients through diagnosis, treatment planning and follow‑up, ensuring comprehensive reproductive care.

Question 4

What fertility treatments and services does Invimed offer?

Accepted Answer

Invimed provides a full spectrum of assisted reproduction techniques. Core IVF services include conventional in vitro fertilisation, intracytoplasmic sperm injection (ICSI) and high‑resolution IMSI for severe male factor cases. The clinic also offers intrauterine insemination (IUI), egg freezing for fertility preservation, and a dedicated egg‑donation programme with a 68% success rate. Additional options comprise embryo adoption, pre‑implantation genetic testing (PGT‑A) and comprehensive genetic diagnostics such as Rodinia and VERACITY panels. Patients can access hormonal stimulation protocols, natural cycle IVF, and specialised support for recurrent implantation failure. Complementary services include male factor assessment, andrology, nutritional counselling, psychological support and tele‑consultations, creating an integrated pathway from diagnosis to successful pregnancy.

Question 5

What IVF laboratory technology does Invimed use?

Accepted Answer

Invimed’s IVF laboratory employs cutting‑edge equipment to maximise embryo quality and safety. The clinic utilises the Ferti Proof™ electronic identification system from Vitrolife, which provides barcode‑based tracking of gametes and embryos at every stage, eliminating manual errors. In the Poznań centre, the RI Witness system offers independent, real‑time monitoring of laboratory processes and ensures traceability of all biological material. Semen analysis is performed with CASA (Computer‑Assisted Semen Analysis) technology for precise motility and morphology assessment. Time‑lapse incubators and controlled‑temperature workstations support continuous embryo culture, while certified ESHRE embryologists oversee all procedures. These technologies are complemented by strict quality‑management protocols that meet both Polish health regulations and international ESHRE standards.

Question 6

Does Invimed offer egg donation for IVF treatment?

Accepted Answer

Yes, Invimed runs a comprehensive egg‑donation programme that allows patients to use donor oocytes when their own ovarian reserve is insufficient. The service includes a thorough donor screening process, legal consent management and coordinated embryo creation. Clinical data show a 68% pregnancy rate per transfer for egg‑donation cycles, meaning seven out of ten recipients achieve a successful pregnancy. The programme is integrated with Invimed’s IVF laboratory, which employs the Ferti Proof™ tracking system and RI Witness quality controls to ensure the highest safety and efficacy standards throughout the donation and fertilisation process.

InviMed Warszawa Mokotów Klinika Leczenia Niepłodności

About InviMed Warszawa Mokotów Klinika Leczenia Niepłodności

check_circleWhy choose InviMed Warszawa Mokotów Klinika Leczenia Niepłodności?

warningWhat to watch out for at InviMed Warszawa Mokotów Klinika Leczenia Niepłodności?

Fertility Treatment Prices at InviMed Warszawa Mokotów Klinika Leczenia Niepłodności

InviMed Warszawa Mokotów Klinika Leczenia Niepłodności — Patient Reviews

InviMed Warszawa Mokotów Klinika Leczenia Niepłodności — FAQ

Contact & Location

More Fertility Clinics in Poland

Fertility Clinic INVICTA

Fertility Clinic INVICTA

Klinika Bocian Katowice - Diagnostyka i leczenie niepłodności, In vitro